Dr. Zach Reitman (Harvard University/Dana-Farber Cancer Institute) is one of three Defeat DIPG ChadTough Fellowship award winners from 2017. Dr. Reitman is attending the ISPNO 2018 Conference this week, where the Michael Mosier Defeat DIPG Foundation and The ChadTough Foundation are sharing about their grant and fellowship program.
Dr. Reitman took the time to talk about the work he is doing around Diffuse Intrinsic Pontine Glioma (DIPG) thanks to the fellowship he received.
“The Michael Mosier Defeat DIPG Foundation and ChadTough have given me an opportunity to focus on research on DIPGs in the last two years of my residency, to really move some projects forward and see if we can come up with some new therapies for this devastating disease,” he said.
ISPNO is a bi-annual conference attended by researchers and physicians from around the globe. This year, there is a palpable excitement around the work being done for DIPG, something Dr. Reitman commented on.
“I’m amazed that at this event, there’s entire sessions dedicated to DIPG – many, many posters on different ideas to go at this disease,” he said. “I think 10 years ago this was a disease that was somewhat overlooked. It’s uncommon, people were almost a bit nihilistic because it’s such a deadly tumor. I think there’s a lot of hope now because some big discoveries have been made over the past decade that are hopefully lead to some advances.”
Watch the full video with Dr. Reitman: